Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs

BACKGROUND: Among pediatric patients with multidrug-resistant tuberculosis (MDR-TB), limited data exist regarding treatment outcomes in the context of the new and repurposed second-line TB drugs (SLDs). We aimed to describe the treatment outcomes among pediatric MDR-TB patients receiving new and rep...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Pediatric Infect Dis Soc
Glavni autori: Madzgharashvili, Tea, Salindri, Argita D, Magee, Matthew J, Tukvadze, Nestani, Avaliani, Zaza, Blumberg, Henry M, Kempker, Russell R, Lomtadze, Nino
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087132/
https://ncbi.nlm.nih.gov/pubmed/33347564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jpids/piaa139
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items